|
GB0117396D0
(en)
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
AR036375A1
(es)
|
2001-08-30 |
2004-09-01 |
Novartis Ag |
Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
|
|
SE0201980D0
(sv)
*
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
EP1927594A1
(en)
|
2003-01-14 |
2008-06-04 |
Arena Pharmaceuticals, Inc. |
1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
|
BRPI0406761A
(pt)
*
|
2003-01-14 |
2005-12-20 |
Arena Pharm Inc |
Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
AR045697A1
(es)
|
2003-07-14 |
2005-11-09 |
Arena Pharm Inc |
Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo
|
|
EP1724264A1
(en)
*
|
2004-03-10 |
2006-11-22 |
Ono Pharmaceutical Co., Ltd. |
Nitriles and medicinal compositions containing the same as the active ingredient
|
|
TW200614993A
(en)
|
2004-06-11 |
2006-05-16 |
Akzo Nobel Nv |
4-phenyl-pyrimidine-2-carbonitrile derivatives
|
|
US7326715B2
(en)
|
2005-09-23 |
2008-02-05 |
N.V. Organon |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
|
TW200745055A
(en)
*
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
|
TW200734338A
(en)
*
|
2006-01-16 |
2007-09-16 |
Organon Nv |
6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
|
|
US7687515B2
(en)
|
2006-01-17 |
2010-03-30 |
N.V. Organon |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
EP2035422A1
(en)
*
|
2006-06-23 |
2009-03-18 |
AstraZeneca AB |
Pteridine derivatives and their use as cathespin inhibitors
|
|
US20080269241A1
(en)
*
|
2007-02-15 |
2008-10-30 |
Darin Allen |
Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
|
|
US20090118274A1
(en)
*
|
2007-02-15 |
2009-05-07 |
Darin Allen |
Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
|
|
US20090099157A1
(en)
*
|
2007-02-15 |
2009-04-16 |
Ameriks Michael K |
Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
|
|
US20080200454A1
(en)
*
|
2007-02-15 |
2008-08-21 |
Ameriks Michael K |
Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
|
|
US20080207683A1
(en)
*
|
2007-02-15 |
2008-08-28 |
Darin Allen |
Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
|
|
EP1972630A1
(en)
*
|
2007-03-02 |
2008-09-24 |
Glaxo Group Limited |
Purines as cysteine protease inhibitors
|
|
EP2118106A1
(en)
*
|
2007-03-02 |
2009-11-18 |
Glaxo Group Limited |
Purines as cysteine protease inhibitors
|
|
TW200911803A
(en)
*
|
2007-07-16 |
2009-03-16 |
Organon Nv |
6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
|
|
US7932251B2
(en)
|
2007-07-16 |
2011-04-26 |
N.V. Organon |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
WO2009107767A1
(ja)
*
|
2008-02-29 |
2009-09-03 |
大日本住友製薬株式会社 |
Ｈ４受容体アンタゴニスト作用を有する新規２環性ピリミジン誘導体
|
|
JP5575110B2
(ja)
|
2008-04-21 |
2014-08-20 |
レクシコン ファーマシューティカルズ インコーポレイテッド |
Ｌｉｍｋ２阻害剤、それらを含む組成物、及びそれらの使用の方法
|
|
WO2010059418A1
(en)
*
|
2008-11-19 |
2010-05-27 |
The Government Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Services |
Substituted triazine and purine compounds, methods of inhibiting cruzain and rhodesain and methods of treating chagas disease and african trypanosomiasis
|
|
US8026236B2
(en)
|
2009-01-16 |
2011-09-27 |
N.V. Organon |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
TW201035094A
(en)
|
2009-01-16 |
2010-10-01 |
Organon Nv |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
GB0917934D0
(en)
|
2009-10-13 |
2009-11-25 |
Syngenta Ltd |
Herbicidal compounds
|
|
US9115126B2
(en)
|
2010-01-15 |
2015-08-25 |
Merck Sharp & Dohme B.V. |
1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
SG188548A1
(en)
|
2010-09-22 |
2013-04-30 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
EP3091085B1
(en)
|
2010-10-06 |
2019-02-27 |
Institució Catalana de Recerca I Estudis Avançats |
Method of designing a therapy for breast cancer metastasis
|
|
EP2650682A1
(en)
|
2012-04-09 |
2013-10-16 |
Fundació Privada Institut de Recerca Biomèdica |
Method for the prognosis and treatment of cancer metastasis
|
|
MX355055B
(es)
|
2012-04-17 |
2018-04-03 |
Astellas Pharma Inc |
Compuesto heterociclico aromatico biciclico nitrogenado.
|
|
CA2875918A1
(en)
|
2012-06-06 |
2013-12-12 |
Fundacio Institut De Recerca Biomedica (Irb Barcelona) |
Method for the diagnosis, prognosis and treatment of lung cancer metastasis
|
|
US10119171B2
(en)
|
2012-10-12 |
2018-11-06 |
Inbiomotion S.L. |
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
|
|
HK1213946A1
(zh)
|
2012-10-12 |
2016-07-15 |
Inbiomotion S.L. |
用於使用c-maf对前列腺癌转移进行诊断、预後和治疗的方法
|
|
ES2652514T3
(es)
|
2012-11-08 |
2018-02-02 |
Pfizer Inc. |
Compuestos heteroaromáticos como ligandos de dopamina D1
|
|
US20160032399A1
(en)
|
2013-03-15 |
2016-02-04 |
Inbiomotion S.L. |
Method for the Prognosis and Treatment of Renal Cell Carcinoma Metastasis
|
|
BR112015023783A2
(pt)
|
2013-03-15 |
2017-10-24 |
Fundacio Inst De Recerca Biomedica Irb Barcelona |
método para diagnóstico e tratamento de metastase no câncer
|
|
JP6550045B2
(ja)
|
2013-10-09 |
2019-07-24 |
フンダシオ、インスティトゥト、デ、レセルカ、ビオメディカ（イエレベ、バルセロナ）Ｆｕｎｄａｃｉｏ Ｉｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｅｒｃａ Ｂｉｏｍｅｄｉｃａ （Ｉｒｂ Ｂａｒｃｅｌｏｎａ） |
乳がんに由来する骨の転移がんの予後診断および処置のための方法
|
|
EP3137469B1
(en)
|
2014-04-28 |
2019-10-09 |
Pfizer Inc |
Heterocyclic compounds and their use as dopamine d1 ligands
|
|
SG11201700777VA
(en)
|
2014-08-04 |
2017-02-27 |
Nuevolution As |
Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
|
|
AU2015358868A1
(en)
|
2014-12-11 |
2017-06-01 |
Inbiomotion S.L. |
Binding members for human C-Maf
|
|
AU2016205361C1
(en)
|
2015-01-06 |
2021-04-08 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
CA3002551A1
(en)
|
2015-06-22 |
2016-12-29 |
Arena Pharmaceuticals, Inc. |
Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(com pound 1)for use in s1p1 receptor-associated disorders
|
|
PL3458610T3
(pl)
|
2016-05-25 |
2021-11-22 |
Inbiomotion S.L. |
Leczenie raka piersi w oparciu o status c-MAF
|
|
CA3053418A1
(en)
|
2017-02-16 |
2018-08-23 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of primary biliary cholangitis
|
|
US11654153B2
(en)
|
2017-11-22 |
2023-05-23 |
Inbiomotion S.L. |
Therapeutic treatment of breast cancer based on c-MAF status
|
|
KR102054910B1
(ko)
*
|
2017-12-19 |
2019-12-12 |
한림제약(주) |
피롤로[2,3-d]피리미딘 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
|
|
CA3102136A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
US12350260B2
(en)
|
2019-04-05 |
2025-07-08 |
Universite De Bretagne Occidentale |
Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning
|
|
TWI872177B
(zh)
|
2019-12-20 |
2025-02-11 |
丹麥商紐韋盧森公司 |
對核受體具有活性之化合物
|
|
US11447479B2
(en)
|
2019-12-20 |
2022-09-20 |
Nuevolution A/S |
Compounds active towards nuclear receptors
|
|
CA3174176A1
(en)
|
2020-03-31 |
2021-10-07 |
Sanne Schroder Glad |
Compounds active towards nuclear receptors
|
|
JP7713953B2
(ja)
|
2020-03-31 |
2025-07-28 |
ヌエヴォリューション・アクティーゼルスカブ |
核内受容体に対して活性な化合物
|
|
WO2024105159A1
(en)
*
|
2022-11-16 |
2024-05-23 |
University Of Zurich |
Ligands of the m6a-rna readers
|